Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

151
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Latest news on GLAXOSMITHKLINE PLC
1h ago GLAXOSMITHKLINE : *traders: barclays raises glaxosmithkline to 'overweight' ('eq..
1d agoDJHealth Care Down as Biogen, Intuitive Surgical Weigh -- Health Care Roundup
1d ago Global shares falter as Wall St. tumbles, bond prices fall
1d ago Shares falter as Wall Street tumbles, bond prices fall
1d ago EXCLUSIVE- ADVENT, AVISTA NEAR DEAL : sources
1d ago GSK eyes prime FTSE 100 slot for standalone HIV drugs business
1d ago Motor insurers help Britain's FTSE edge higher
1d ago GLAXOSMITHKLINE : AppZero selected by GlaxoSmithKline for Windows Server 2003 Mo..
1d agoDJLONDON MARKETS : Glaxo Gives FTSE 100 A Shot In The Arm
1d ago GLAXOSMITHKLINE : *s&p capital iq raises glaxosmithkline to 'buy' ('hold') - pri..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF